Bellwether Advisors, LLC Bristol Myers Squibb CO Transaction History

Bellwether Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$57.89 - $64.73 $24,776 - $27,704	-428 Reduced 1.78%	23,584 $1.37 Million
Q2 2023 Aug 04, 2023	SELL	$63.71 - $70.74 $4,332 - $4,810	-68 Reduced 0.28%	24,012 $1.54 Million
Q1 2023 May 05, 2023	SELL	$65.71 - $74.53 $102,836 - $116,639	-1,565 Reduced 6.1%	24,080 $1.67 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $410,469 - $486,053	-5,994 Reduced 18.94%	25,645 $1.84 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $27 - $15,982	208 Added 0.66%	31,639 $2.25 Million
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $35,656 - $39,270	-491 Reduced 1.54%	31,431 $2.42 Million
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $130,267 - $151,861	-2,429 Reduced 7.07%	31,922 $1.99 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $67,098 - $78,597	-1,134 Reduced 3.2%	34,351 $2.03 Million
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $351,463 - $382,743	-5,677 Reduced 13.79%	35,485 $2.37 Million
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $233,918 - $263,089	-3,942 Reduced 8.74%	41,162 $2.6 Million
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $2.6 Million - $2.95 Million	45,104 New	45,104 $2.8 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Bellwether Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellwether Advisors, LLC with notifications on news.